Note: Ingredients listed on restricted chemical lists
EC/CAS
200-661-7/67-63-0
Name of the chemical
Propan-2-ol
Concentration
≥50-≤75
EC/CAS
232-475-7/8050-09-7
Name of the chemical
Rosin
Concentration
≥10-≤19
EC/CAS
204-673-3/124-04-9
Name of the chemical
adipic acid
Concentration
≤5
General Information
Revision date
2023-01-19
Product name
Circuitworks No Clean Flux Dispensing Pen (UK - Great Britain)
1.2.1 Relevant identified uses
Fluxing agents
supplier name
Bay 150
Manufacturer Name
Chemtronics
Emergency telephone
0845 46 47
Icons in SDS
Company Information
company name
ITW Contamination Control BV
e-mail address of the competent person responsible for the Safety Data Sheet
info@itw-cc.com, customerservice.shannon@itwpp.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H317, H319, H336
Hazard statements
Code
Statements
H225
Highly flammable liquid and vapour
H317
May cause an allergic skin reaction
H319
Causes serious eye irritation
H336
May cause drowsiness or dizziness
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Product definition
Mixture Classification according to UK CLP/GHS Flam. Liq. 2, H225 Eye Irrit. 2, H319 Skin Sens. 1, H317 STOT SE 3, H336
Ingredients of unknown ecotoxicity
Contains 3% of components with unknown hazards to the aquatic environment See Section 16 for the full text of the H statements declared above See Section 11 for more detailed information on health effects and symptoms
Signal word
Danger
Hazard statements
Highly flammable liquid and vapour. May cause an allergic skin reaction. Causes serious eye irritation. May cause drowsiness or dizziness.
Prevention
Wear protective gloves. Wear eye or face protection. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Avoid breathing vapour.
Response
IF INHALED: Call a POISON CENTER or doctor if you feel unwell. Take off contaminated clothing and wash it before reuse. IF ON SKIN: Wash with plenty of water. If skin irritation or rash occurs: Get medical advice or attention. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.
Storage
Store in a well-ventilated place. Keep container tightly closed.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
FOR INDUSTRIAL USE ONLY For professional use only. UK Caution exposure to fumes from this material may cause certain sensitive individuals to develop eczema and/or occupational asthma. May cause sensitization by inhalation and skin contact. Sensitized persons may subsequently show asthmatic symptoms when exposed to atmospheric concentrations well below the OEL.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted with child-resistant fastenings : Not applicable.
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to UK CLP/GHS Flam. Liq. 2, H225 Eye Irrit. 2, H319 Skin Sens. 1, H317 STOT SE 3, H336 The product is classified as hazardous according to UK CLP Regulation SI 2019/720 as amended. Ingredients of unknown : 10 percent of the mixture consists of component(s) of unknown acute dermal toxicity toxicity 81 percent of the mixture consists of component(s) of unknown acute inhalation toxicity Ingredients of unknown : Contains 3% of components with unknown hazards to the aquatic environment ecotoxicity See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.